10x Genomics Inc.
TXG | NASDAQ
$82.38
+$3.28 (+4.15%)
Sep 22, 2026, 1:19 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 473.97M | 344.07M | 359.28M | 219.75M | 587.45M | 663.6M |
Short-Term Investments | 49.44M | 49.34M | 29.41M | 210.24M | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | 7.6M | n/a |
Other Long-Term Assets | 2.91M | 4.13M | 3.06M | 7.37M | 3.32M | 12.8M |
Receivables | 82.49M | 87.86M | 114.83M | 104.21M | 85.25M | 51.21M |
Inventory | 56.34M | 83.11M | 73.71M | 81.63M | 59.97M | 29.96M |
Other Current Assets | 22.21M | 20.02M | 18.79M | 19.21M | 1.03M | 16.57M |
Total Current Assets | 684.45M | 584.39M | 596.02M | 635.04M | 747.59M | 774.37M |
Property-Plant & Equipment | 287.16M | 309.94M | 344.93M | 359.21M | 230.41M | 119.82M |
Goodwill & Intangibles | 66.84M | 20.18M | 21.13M | 27.37M | 29.91M | 22.35M |
Total Long-Term Assets | 356.91M | 334.25M | 369.12M | 393.95M | 271.24M | 154.98M |
Total Assets | 1.04B | 918.64M | 965.14M | 1.03B | 1.02B | 929.34M |
Account Payables | 12.73M | 12.91M | 15.74M | 21.6M | 17.35M | 4.71M |
Deferred Revenue | 23.9M | 20.66M | 13.15M | 7.87M | 5.34M | 6.2M |
Short-Term Debt | 10.99M | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 63.33M | 41.84M | 33.96M | 29.74M | 40.91M | 21.63M |
Total Current Liabilities | 153.45M | 117.63M | 127.16M | 130.96M | 110.36M | 118.13M |
Long-Term Debt | 73.38M | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | -65.67M | 5.03M | 4.28M | 2.98M | 14.05M | 15.1M |
Total Long-Term Liabilities | 91.59M | 90.87M | 96.94M | 92.28M | 90.9M | 72.14M |
Total Liabilities | 245.04M | 208.5M | 224.1M | 223.24M | 201.26M | 190.27M |
Total Debt | 157.74M | 82.61M | 95.37M | 95.18M | 81.98M | 62.98M |
Book Value | 796.33M | 710.13M | 741.04M | 805.74M | 817.57M | 739.07M |
Book Value Per Share | 6.38 | 5.90 | 6.32 | 7.08 | 7.41 | 7.31 |
Common Stock | 2K | 2K | 2K | 2K | 2K | 2K |
Retained Earnings | -1.51B | -1.47B | -1.28B | -1.03B | -863.32M | -805.1M |
Comprehensive Income | 225K | -493K | -429K | -4.34M | 22K | -50K |
Shareholders Equity | 796.33M | 710.13M | 741.04M | 805.74M | 817.57M | 739.07M |
Total Investments | 49.44M | 49.34M | 29.41M | 210.24M | 7.6M | n/a |
Add to Watchlist
Select watchlists to add or remove TXG